Share: MISSISSAUGA, Ontario and TORONTO, March 15, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:MBX, OTCQB:MBXBF, Microbix®)), a life sciences innovator and exporter, and Seegene Canada Inc. (Seegene®), a provider of leading-edge molecular diagnostics assays and instruments (made by Seegene Inc. of Seoul, Korea), are pleased to announce a collaboration under which Seegene will distribute and recommend Microbix's new COVID-variant Quality Assessment Products (QAPs™) to monitor the workflow accuracy of Seegene Allplex® assays across Canada. In this collaboration, Seegene become...